MDS-EB
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Allogenic NK Cell Transfusion Azacitidine MDS-EB (NCT04599426) | The Second Hospital of Shandong University | 2020-12-01 |
| A Phase I Open-Label Dose Escalation Study of Intravenous INKmune In Patients With MDS or AML (NCT05933070) | Inmune Bio, Inc. | 2020-06-15 |
| Low-dose AZA Combined With Short Term CAG Derived Regimen as a Bridging Treatment in Patients With Advanced MDS Prior to Allo-HSCT (NCT04216355) | Fujian Medical University | 2020-01-01 |
Track MDS-EB automatically
Every clearance here is in the API, with alerts when new ones post.